CRDL — Cardiol Therapeutics Inc.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1702123 ·
Last close
$1.71
Market Cap
$199.77M
52W High
$2.34
52W Low
$0.88
ADV30
1,529,217
Next earnings
2026-11-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -7,937,921 | -6,081,827 | 29,357,847 | 26,081,066 | 5,328,926 |
| Mar 2026 | 0 | — | -9,706,794 | -10,818,589 | 31,406,607 | 27,673,191 | 7,203,302 |
| Dec 2025 | 0 | — | -8,030,975 | -7,212,569 | 23,619,933 | 21,416,684 | 5,742,215 |
| Sep 2025 | 0 | — | -10,180,100 | -9,964,281 | 12,947,801 | 11,622,408 | 3,386,926 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-24,218,514
Investing CF
$-60,130
Financing CF
$29,153,456
CapEx
$-60,130
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.42
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-223,891,564
Inventory
—
Receivables
$339,706
ST Investments
—
EBIT TTM
$-35,594,027
Pretax Income TTM
$-36,349,810
Interest Exp TTM
—
Analysts
4
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -34,316,296 | -33,818,874 | 23,619,933 | 5,742,215 | 17,877,718 | -23,854,650 |
| Dec 2024 | 0 | -40,276,651 | -36,677,299 | 31,863,751 | 7,135,268 | 24,728,483 | -25,060,867 |
| Dec 2023 | 0 | -29,785,504 | -28,128,292 | 36,700,508 | 8,454,001 | 28,246,507 | -25,180,441 |
| Dec 2022 | 0 | -41,335,878 | -30,930,647 | 62,028,518 | 9,826,930 | 52,201,588 | -27,220,345 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.24
Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $2.50 · spot: $1.66 · call volume: 3 · put volume: 24
Expected Move to 2026-12-18:
±$2.33
(139.71%) —
implied range
$-0.66 –
$3.99
· ATM straddle on $2.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CMPX | Compass Therapeutics, Inc. | $203.50M | $1.13 | — |
| TARA | Protara Therapeutics, Inc. | $193.83M | $3.28 | — |
| IPHA | Innate Pharma SA | $189.89M | $1.70 | — |
| ACOG | Alpha Cognition Inc. | $184.46M | $8.47 | — |
| IPHYF | Innate Pharma SA | $184.31M | $1.65 | — |
News headlines (Yahoo Finance, 1h cache)
Cardiol Therapeutics Achieves Phase III MAVERIC Enrollment Target Ahead of Schedule and Expands Pivotal Trial to Strengthen Assessment of CardiolRx™'s Efficacy
2026-09-23 10:00 · Yahoo
Cardiol Therapeutics Announces Warrant Exercise for Over USD $7 Million in Proceeds
2026-09-16 11:27 · Yahoo
Cardiol Therapeutics Files US$150 Million Preliminary Base Shelf Prospectus Including Additional Disclosure Following Review by Staff of the Ontario Securities Commission
2026-09-10 21:00 · Yahoo
Cardiol Therapeutics to Participate in a Fireside Chat at the H.C. Wainwright 28th Annual Global Investment Conference
2026-09-09 11:27 · Yahoo
Is Cardiol Therapeutics (CRDL) Stock Outpacing Its Medical Peers This Year?
2026-08-25 13:40 · Yahoo
Cardiol Therapeutics Inc. (CRDL) is a Great Momentum Stock: Should You Buy?
2026-08-24 16:00 · Yahoo
Cardiol Therapeutics Advances CardiolRx in Pivotal Phase III Pericarditis Trial
2026-08-12 12:01 · Yahoo
5 Small Drug Stocks Poised to Benefit From a Biotech Recovery
2026-09-14 13:30 · Yahoo
Is Aspen Pharmacare (APNHY) Outperforming Other Medical Stocks This Year?
2026-09-10 13:40 · Yahoo
Cardiol Therapeutics to Participate in Fireside Chat at Canaccord Genuity's 46th Annual Growth Conference
2026-08-05 11:27 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.